retatrutide clinical trial data Phase 3: TRIUMPH Program Results 2026 Eli Lilly infiltrates anti-obesity market

Our experienced providers will guide you through each step, whether you choose to self-administer at home or prefer to receive your injections in our clinic

For individuals with diabetes, regularly monitoring blood sugar levels can provide valuable insights into how different foods and activities affect their condition

Decision factors: Weight loss goals: Want maximum weight loss and can tolerate side effects: Tirzepatide (Zepbound) shows ~4% greater weight loss than semaglutide on average Want proven cardiovascular benefits: Semaglutide has demonstrated 20% reduction in major cardiovascular events in the SELECT trial Want to try oral option: Oral semaglutide (Rybelsus) for diabetes, though weight loss is less than injectable Side effect sensitivity: Some people tolerate one better than the other

No GLP-1 weight loss patches are currently approved by the MHRA (Medicines and Healthcare products Regulatory Agency)